Cargando…
Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Springer-Verlag
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064899/ https://www.ncbi.nlm.nih.gov/pubmed/21327932 http://dx.doi.org/10.1007/s00280-011-1582-3 |
| _version_ | 1782200933694832640 |
|---|---|
| author | Helbig, Grzegorz Moskwa, Andrzej Hus, Marek Piszcz, Jarosław Swiderska, Alina Urbanowicz, Alina Całbecka, Małgorzata Seferyńska, Ilona Raźny, Małgorzata Rodzaj, Marek Żuk, Ewa Kyrcz-Krzemień, Sławomira |
| author_facet | Helbig, Grzegorz Moskwa, Andrzej Hus, Marek Piszcz, Jarosław Swiderska, Alina Urbanowicz, Alina Całbecka, Małgorzata Seferyńska, Ilona Raźny, Małgorzata Rodzaj, Marek Żuk, Ewa Kyrcz-Krzemień, Sławomira |
| author_sort | Helbig, Grzegorz |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-3064899 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | Springer-Verlag |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-30648992011-04-21 Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia Helbig, Grzegorz Moskwa, Andrzej Hus, Marek Piszcz, Jarosław Swiderska, Alina Urbanowicz, Alina Całbecka, Małgorzata Seferyńska, Ilona Raźny, Małgorzata Rodzaj, Marek Żuk, Ewa Kyrcz-Krzemień, Sławomira Cancer Chemother Pharmacol Letter to the Editor Springer-Verlag 2011-02-17 2011 /pmc/articles/PMC3064899/ /pubmed/21327932 http://dx.doi.org/10.1007/s00280-011-1582-3 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Helbig, Grzegorz Moskwa, Andrzej Hus, Marek Piszcz, Jarosław Swiderska, Alina Urbanowicz, Alina Całbecka, Małgorzata Seferyńska, Ilona Raźny, Małgorzata Rodzaj, Marek Żuk, Ewa Kyrcz-Krzemień, Sławomira Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia |
| title | Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia |
| title_full | Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia |
| title_fullStr | Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia |
| title_full_unstemmed | Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia |
| title_short | Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia |
| title_sort | durable remission after treatment with very low doses of imatinib for fip1l1-pdgfrα-positive chronic eosinophilic leukaemia |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064899/ https://www.ncbi.nlm.nih.gov/pubmed/21327932 http://dx.doi.org/10.1007/s00280-011-1582-3 |
| work_keys_str_mv | AT helbiggrzegorz durableremissionaftertreatmentwithverylowdosesofimatinibforfip1l1pdgfrapositivechroniceosinophilicleukaemia AT moskwaandrzej durableremissionaftertreatmentwithverylowdosesofimatinibforfip1l1pdgfrapositivechroniceosinophilicleukaemia AT husmarek durableremissionaftertreatmentwithverylowdosesofimatinibforfip1l1pdgfrapositivechroniceosinophilicleukaemia AT piszczjarosław durableremissionaftertreatmentwithverylowdosesofimatinibforfip1l1pdgfrapositivechroniceosinophilicleukaemia AT swiderskaalina durableremissionaftertreatmentwithverylowdosesofimatinibforfip1l1pdgfrapositivechroniceosinophilicleukaemia AT urbanowiczalina durableremissionaftertreatmentwithverylowdosesofimatinibforfip1l1pdgfrapositivechroniceosinophilicleukaemia AT całbeckamałgorzata durableremissionaftertreatmentwithverylowdosesofimatinibforfip1l1pdgfrapositivechroniceosinophilicleukaemia AT seferynskailona durableremissionaftertreatmentwithverylowdosesofimatinibforfip1l1pdgfrapositivechroniceosinophilicleukaemia AT raznymałgorzata durableremissionaftertreatmentwithverylowdosesofimatinibforfip1l1pdgfrapositivechroniceosinophilicleukaemia AT rodzajmarek durableremissionaftertreatmentwithverylowdosesofimatinibforfip1l1pdgfrapositivechroniceosinophilicleukaemia AT zukewa durableremissionaftertreatmentwithverylowdosesofimatinibforfip1l1pdgfrapositivechroniceosinophilicleukaemia AT kyrczkrzemiensławomira durableremissionaftertreatmentwithverylowdosesofimatinibforfip1l1pdgfrapositivechroniceosinophilicleukaemia |